Ascendia Pharmaceuticals LLC is a leading pharmaceutical contract formulation development and manufacturing organization (CDMO) based in North Brunswick, NJ. They offer a wide array of pharmaceutical development capabilities, specializing in the manufacturing and analysis of drug product dosage forms. Ascendia provides rapid, comprehensive, and cost-effective solutions for difficult formulation development projects, with expertise in areas such as controlled release, poorly soluble and low bioavailability drugs, and biological formulation development.
With a focus on early-stage, IND-enabling formulations for toxicology and PK studies, Ascendia is known for its ability to deliver rapid development through Phase I clinical trial materials. Their sophisticated formulations cover every stage of development, from molecule to formulation to clinical, and they have a strong track record in complex generics, animal health formulations, and high potency molecules. Ascendia's commitment to excellence and innovation has solidified their position as a trusted partner in the pharmaceutical industry.
Generated from the website